OGOscar Gonzalez

Oscar Gonzalez

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Oscar Gonzalez has a total of 134 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Preoperative BMI and Five-Year Proportional Weight-Loss Maintenance After Roux-en-Y Gastric Bypass: A Retrospective Cohort Study

    by Carlos Petrola Chacón, Oscar González, Alex Hugué, Nares Arroyo, Clara Nieto, Sara Sánchez, Sandra Castro, Gonzalo Sapisochin

  • Obesity related pathophysiological aspects favouring Gastroesophageal Reflux Disease

    by Amador García Ruiz de Gordejuela, Ainitze Ibarzabal Olano, Carlos Gustavo Petrola Chacón, Óscar González López


  • Comment on: Gastric Ischaemia After SADI with Right Gastric Artery Ligation

    by Amador García Ruiz de Gordejuela, Marc Beisani, Andrés Sánchez-Pernaute, Carlos Gustavo Petrola Chacón, Óscar González López


  • Open Access

    Analysis of the Variability in Different Criteria to Define the Success of Bariatric Surgery: Retrospective Study 5-Year Follow-Up after Sleeve Gastrectomy and Roux-en-Y Gastric Bypass

    by Sergi Sanchez-Cordero, Amador Garcia Ruiz de Gordejuela, Ramon Vilallonga, Oscar Gonzalez, Ana Ciscar, Andreea Ciudin, Alba Zabalegui, Manuel Armengol

    (1) Background: The current criteria for defining good or bad responders to bariatric surgery based on the percentage of weight loss do not properly reflect the therapeutic impact of the main bariatric techniques. At present there is an urgent need to fill this gap and provide scientific evidence that better define the success or failure of bariatric surgery in the long term. (2) Methods: This is a retrospective database study of a prospective cohort with 5-year follow-up. We established the success or failure of bariatric surgery in terms of weight loss according to a selected criterion: (1) Halverson and Koehler; (2) Reinhold modified by Christou; (3) Biron; (4) TWL > 20%; (5) percentage of changeable weight (AWL > 35%). We analyzed sensitivity and specificity for successful weight loss. (3) Results: 223 (38.7%) patients underwent sleeve gastrectomy (LSG) and 353 (61.2%) underwent laparoscopic Roux-en-Y gastric bypass (LRYGBP). The success rates at 5 years are: EWL > 50% 464 (80%), Reinhold 436 (75.6%), Biron 530 (92%), TWL > 20% 493 (85.5%), AWL < 35% 419 (72.7); ≥50% EWL and alterable weight loss AWL > 35 were the most adequate criteria as their specificities and sensibility were far above >80%. (4) Conclusions: The present study shows how the different definitions of success or failure are inconsistent in relation to the outcomes of BS. However, there are some criteria that associate statistically significant differences for the resolution of comorbidities and show the highest sensitivity and specificity rates.


  • Lymphocytic Thyroiditis Transcriptomic Profiles Support the Role of Checkpoint Pathways and B Cells in Pathogenesis

    by Daniel Álvarez-Sierra, Ana Marín-Sánchez, Aroa Gómez-Brey, Irene Bello, Enric Caubet, Pablo Moreno-Llorente, Anna Petit, Carles Zafón, Carmela Iglesias, Óscar González, et al.

    Background. Autoimmune thyroid diseases are the most common types of autoimmune diseases, but their physiopathology is still relatively unexplored. GTEX is a publicly available repository containing RNAseq data including profiles from thyroid. A 14.8% of these glands were affected by focal lymphocytic thyroiditis and 6.3% were annotated as Hashimoto. We interrogated these data to improve the characterization of the infiltrating cells and to identify new molecular pathways active in autoimmune thyroiditis. Methods. Histological GTEX images of 336 thyroid samples were classified into three categories, i.e., non-infiltrated thyroid, small focal infiltrated thyroid, and extensive lymphoid infiltrated thyroid. Differentially expressed genes among these categories were identified and subjected to in silico pathway enrichment analysis according. CIBERSORTx deconvolution was used to characterize infiltrating cells. Results. As expected, most of the transcriptional changes were dependent on tissue infiltration. Upregulated genes in tissues include—in addition to lineage-specific B and T cell genes—a broad representation of inhibitory immune checkpoint receptors expressed by B and T lymphocytes. CIBERSORTx analysis identified 22 types of infiltrating cells showed that T cells predominate 3:1 over B cells in the glands with small infiltrates, only by 1.7:1 in those with large infiltrates. Follicular helper and memory CD4 T cells were significantly more abundant in glands with large infiltrates (p < 0.0001), but the most prominent finding in these glands was an almost six-fold increase in the number of naïve B cells (p < 0.0001). A predominance of M2 macrophages over M1 and M0 macrophages was observed in the three gland categories (p < 0.001). Conclusions. Analysis of transcriptomic RNA-seq profiles constitutes a rich source of information for the analysis of autoimmune tissues. High resolution transcriptomic data analysis of thyroid glands indicates the following: 1) in all infiltrated glands, active autoimmune response coexists with a suppressor counteracting mechanisms involving several inhibitory checkpoint receptor pairs 2) glands with small infiltrates contain an unexpected relatively high proportion of B lymphocytes, and 3) in highly infiltrated glands there is a distinct transcriptomic signature of active tertiary lymphoid organs. These results support the concept that the autoimmune response is amplified in the thyroid tissue.


  • Analysis of the Management of Cholelithiasis in Bariatric Surgery Patients: a Single-Center Experience

    by Carlos Gustavo Petrola Chacón, Ramón Vilallonga, Óscar González López, Amador García Ruiz de Gordejuela, Marc Beisani, Enric Caubet Busquet, Jose Manuel Fort, Manel Armengol Carrasco

    Purpose Cholelithiasis is an issue in bariatric surgery patients. The incidence of cholelithiasis is increased in morbidly obese patients. After bariatric surgery, the management maybe sometimes challenging. There is no consensus about how to deal with cholelithiasis prior to bariatric surgery. Materials and Methods A retrospective review from our prospectively collected bariatric surgery database. Primary bariatric procedures from 2009 to 2020 were included. Prevalence of cholelithiasis and its management prior to bariatric surgery and the incidence and management of postoperative biliary events were analyzed. Results Over 1445 patients analyzed, preoperatively cholelithiasis was found in 153 (10.58%), and 68 out of them (44.44%) were symptomatic. Seventy-six patients had a concomitant cholecystectomy. In those cases, the bariatric procedure did not show increased operative time, length of stay, morbidity, or mortality compared to the rest of primary bariatric procedures. Twelve patients (15.58%) with previous cholelithiasis and no concomitant cholecystectomy presented any kind of biliary event and required cholecystectomy. De novo cholelithiasis rate requiring cholecystectomy was 3.86%. Postoperative biliary events both in de novo and persistent cholelithiasis population did not show any difference between the type of surgery, weight loss, and other characteristics. Conclusions Cholelithiasis was present in 10.58% of our primary bariatric surgery population. Concomitant cholecystectomy was safe in our series. Non-surgical management of asymptomatic cholelithiasis did not lead to a higher risk of postoperative biliary events. The global postoperative cholecystectomy rate was equivalent to the general population. Graphical abstract


  • Outcomes of Conversion from Sleeve Gastrectomy to Roux-en-Y Gastric Bypass Due to GERD—a Retrospective Analysis of 35 Patients

    by Anna Curell, Marc Beisani, Amador García Ruiz de Gordejuela, Ramon Vilallonga, Mireia Verdaguer Tremolosa, Óscar González López, Enric Caubet Busquet, José Manuel Fort López-Barajas

    Background Sleeve gastrectomy (SG) has become one of the most performed bariatric procedures worldwide. Its main weaknesses are weight regain and gastroesophageal reflux disease (GERD). Conversion to Roux-en-Y gastric bypass (RYGB) is considered the gold standard to manage GERD and related symptoms. Methods Retrospective evaluation from a prospective bariatric surgery database of all our institution’s patients converted from SG to RYGB due to GERD between January 2010 and December 2018. Clinical characteristics and workups before SG and before and after RYGB were analyzed. Results During the study period, 35 patients needed a conversion to RYGB, due to GERD or GERD-related symptoms. Mean age was 48.6 years, 85.7% were women, and mean BMI was 31.4 kg/m2. The interval between SG and RYGB was in a range 7 to 70 months (mean 33 months). All conversions were completed laparoscopically, associating a hiatoplasty in 45.7% of cases. A complete remission of symptoms was observed in 74% of patients, some improvement in 20%, and no relief in 6%. There were 3 cases of hiatal hernia persistence and 2 of recidivism. Only 1 patient presented pathological pHmetry, while moderate esophagitis was demonstrated in 2 patients. Conclusions Conversion to RYGB was effective in almost all patients. Pathological acid exposure and hiatal hernias seem to be the main findings prior to conversion, justifying an exhaustive examination and aggressive approach to the hiatus. Due to the insufficient correlation between symptoms and findings on morphological and functional tests, actively searching for signs of GERD is advisable. Graphical abstract


  • Seeking an Initial-Weight-Independent Metric in a Mediterranean Cohort of Gastric Bypass Patients: the %AWL Revisited

    by Members of the Obesity Section of the Spanish Surgical Association Collaborative Group, Marc Beisani, Fàtima Sabench Pereferrer, Ramón Vilallonga, Óscar González López, Alicia Molina López, Daniel del Castillo Dejardin, Amador García Ruiz de Gordejuela, José Manuel Fort López-Barajas, Manel Armengol Carrasco

    Background Most relative weight-loss metrics follow the formula “Weight loss(%) = 100 · (Initial BMI - Final BMI) / (Initial BMI-a),” where a is the reference point that defines the metric. The percentage of total weight loss (%TWL, a = 0) and percentage of excess weight loss (%EWL, a = 25) are influenced by a patient’s initial weight. Recently, the percentage of alterable weight loss metric (%AWL, a = 13) has been reported to produce initial-weight-independent outcomes. Objectives This study aimed to replicate the methodology used for %AWL determination in a Mediterranean cohort of bariatric patients. Settings Multicenter study in 10 large hospitals in Spain. Methods Two large prospective databases were retrospectively searched for all primary laparoscopic gastric bypass patients with 2 years of follow-up. Outcomes at nadir were expressed and analyzed with 26 different metrics (a from 0 to 25), looking for the metric whose outcomes produced (1) the lowest coefficient of variation, (2) no differences between initially lighter and heavier patients, and (3) no correlation with patients’ initial BMI. Results A cohort of 1793 patients was stratified into 4 gender-age groups: younger women (YW, n = 733), older women (OW, n = 674), younger men (YM, n = 197), and older men (OM, n = 189). The calculations suggested an optimal reference point of 18 kg/m2, defining a new metric (percentage of Mediterranean alterable weight loss, %MAWL). When %TWL, %EWL, %AWL, and %MAWL were tested on the whole sample, only %MAWL produced initial-weight-independent results. Conclusions In our Mediterranean cohort of patients, a reference point of 18 (and not 13) yielded initial-weight-independent outcomes.


  • Open Access

    Retinal Microperimetry: A Useful Tool for Detecting Insulin Resistance-Related Cognitive Impairment in Morbid Obesity

    by Andreea Ciudin, Angel Michael Ortiz, Enzamaria Fidilio, Diana Romero, Marta Sánchez, Marta Comas, Oscar Gonzalez, Ramon Vilallonga, Olga Simó-Servat, Cristina Hernández, et al.

    Background: There is clear association between type 2 diabetes (T2D) and cognitive decline. Retinal microperimetry is a useful tool for detecting cognitive impairment in T2D. Morbid obesity (MO) has been associated with cognitive impairment. Insulin resistance (IR) seems a major determinant, but the data are unclear. The aim of this study was to evaluate the cognitive impairment in MO as well as the utility of retinal microperimetry in identifying these alterations. Methods: In total, 50 consecutive patients with MO were matched by age and gender with 30 healthy controls. All patients underwent cognitive evaluation (Montreal Cognitive Assessment Test-MoCA) and retinal microperimetry, using MAIA microperimeter 3rd generation. Retinal sensitivity and gaze fixation parameters were used for the evaluation of the analysis. Results: MO patients showed a significantly lower neurocognitive performance than the controls: MoCA score 24.94 ± 2.74 vs. 28.95 ± 1.05, p < 0.001. Cognitive function inversely correlated with the HOMA-IR (r = −0.402, p = 0.007). The AUROC for cognitive impairment using microperimetry was 0.807, CI 95% (0.592–0.947), p = 0.017. Conclusions: (1) Systemic insulin resistance is a major underlying mechanism accounting for the higher prevalence of cognitive impairment detected in young MO subjects. (2) Retinal microperimetry is a useful tool for identifying MO patients with cognitive impairment.


  • Accuracy of transcutaneous laryngeal ultrasound for detecting vocal cord paralysis in the immediate postoperative period after total thyroidectomy

    by Marcos de Miguel, Eva M. Peláez, Enric Caubet, Óscar González, Mercedes Velasco, Lidia Rigual

    Article: Accuracy of transcutaneous laryngeal ultrasound for detecting vocal cord paralysis in the immediate postoperative period after total thyroidectomy - Minerva Anestesiologica 2017 December;83(12):1239-47 - Minerva Medica - Journals